Relating to required health benefit plan coverage for gender transition adverse effects and reversals

What it does: Requires health plans, including Medicaid and CHIP, that cover or have covered gender transition procedures to cover their adverse consequences, annual follow-up testing, and treatment to manage, reverse or recover from the procedure, for plans issued or renewed from January 1, 2026. (AI-written summary of the bill; the official record shows the exact version voted)

Question before the chamber: Final passage (third reading)

Read the official record ↗